Clinical Trials Sponsored by Akron Molecules AG
Total 17 results
-
Akron Molecules AGCompleted
-
Wilhelminenspital ViennaAkron Molecules AGCompletedAnalgesic Drugs | Antinociceptive AgentsAustria
-
Molecular Partners AGCompleted
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
Molecular Partners AGCompletedNeoplasmsSwitzerland, Spain, United Kingdom
-
Molecular Partners AGRecruitingLeukemia | Acute | Relapsed | MyeloidNetherlands, France, Lithuania, Switzerland
-
Molecular Partners AGTerminatedEGFR-mutated NSCLC (Disorder)United States
-
Molecular Partners AGCompletedAdvanced Solid TumorFrance
-
Molecular Partners AGTerminated
-
Molecular Partners AGCompletedNeoplasmsGermany, Switzerland, United Kingdom
-
Molecular Partners AGTerminatedAdvanced Malignant Solid TumorNetherlands, France
-
AllerganMolecular Partners AGTerminatedDiabetic Macular EdemaUnited States
-
AllerganMolecular Partners AGTerminatedWet Age-Related Macular DegenerationSwitzerland, France, Czech Republic
-
Novartis PharmaceuticalsMolecular Partners AGTerminatedCOVID-19United States, India, Hungary, Netherlands, South Africa
-
Molecular NeuroImagingRoche Pharma AG; Institute for Neurodegenerative DisordersCompletedAlzheimer's Disease (AD)United States
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaboratorsCompletedCovid19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom